Pharma firms likely to post 11% growth in sales, EBITDA in Q1FY26: Report

Monday, 7 July 2025 (2 hours ago)

0 shares	Share Tweet Save Post Send

Pharma sector: Firms to clock 11% sales, EBITDA growth in Q1FY26

India's pharmaceutical sector is projected to experience an 11% year-on-year growth in sales and EBITDA for Q1 FY26, driven by strong market performance across...
IndiaTimes 22 hours ago

Pharma firms likely to post 11% growth in sales, EBITDA in Q1FY26: Report

You Might Like

Related news from verified sources

Pharma sector: Firms to clock 11% sales, EBITDA growth in Q1FY26